Project Grant HDTRA12510013

Award Date 5/1/25
Completion Date 4/30/30
Dollars Obligated $482K
Federal Grant Program
12.351
Assistance Type
Project Grant
Place of Performance
585 Av. Franklin Delano Roosevelt Ste 202, San Juan, 00936, Puerto Rico
Similar Awards
This $100,000 Project Grant award from the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program supports research by Virginia Polytechnic Institute & State University (Virginia Tech) to identify conserved host responses during emerging virus infections. The 5-year project, awarded on February 5, 2025, will utilize complementary proteomic approaches to advance scientific knowledge and capabilities for defending...
This $500,000 Project Grant awarded by the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program supports the development of human-based, connected multi-organ microphysiological system in vitro models to study alphavirus infection and support countermeasure development. The grant was awarded to George Mason University on July 31, 2024 and has a performance period through July 30, 2029. The research aims to advance...
The Defense Threat Reduction Agency (DTRA) awarded a $200,000 Project Grant under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) federal grant program to the Massachusetts Institute of Technology (MIT). The grant, awarded on February 26, 2025, supports fundamental and applied research to develop innovative materials, detection methods, and scientific understanding for defending against chemical, biological, radiological, nuclear, and high-yield explosive threats....
The federal Project Grant award HDTRA12510007 for $239,385.00, awarded by the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction program (CFDA 12.351), aims to develop color-changing coatings for the selective detection of vesicants (chemical warfare agents). The primary awardee, KRI At Northeastern University, LLC, will conduct research to create biomanufactured enzymes that recognize small molecules modified by vesicants and develop...
The Defense Threat Reduction Agency (DTRA) awarded a $1,000,000 Project Grant to the United Nations Interregional Crime and Justice Research Institute (UNICRI) under the Training and Support - Combating Weapons of Mass Destruction (CFDA 12.501) federal grant program. This 3-year grant, running from September 2024 to September 2027, supports UNICRI's efforts to prevent, detect, and mitigate biological, chemical, radiological, and nuclear threats through collaborative international initiatives....
The Defense Threat Reduction Agency (DTRA) awarded a $8,965,491 Project Grant under the Training and Support - Combating Weapons of Mass Destruction (CFDA 12.501) federal grant program to the World Health Organization (WHO) on June 14, 2024. The primary goal of this 4.5-year project is to develop a properly trained field epidemiology workforce to strengthen the country's capabilities in disease surveillance, epidemiological investigations, prevention, emergency preparedness, and response to...
Philips Research North America, a division of Koninklijke Philips Electronic, received a $399,883 Project Grant award from the Defense Threat Reduction Agency on May 17, 2021 to support research under the Scientific Research - Combating Weapons of Mass Destruction federal grant program. The grant funds the MONITORING EXPOSURE THROUGH STANDOFF HEALTH (MESH) project, which will develop remote monitoring technologies to advance knowledge in detecting and assessing exposure risks from chemical,...
The Defense Threat Reduction Agency (DTRA) awarded a $7,859,649 Project Grant under the federal Training and Support - Combating Weapons of Mass Destruction (CFDA 12.501) grant program to the World Health Organization (WHO). The primary goal of this 4-year grant, with a performance period from October 1, 2024 to September 30, 2028, is to enhance global capacity and capabilities to prevent, detect, and manage biological challenges and risks. The award supports WHO's efforts to strengthen...
The Defense Threat Reduction Agency (DTRA) awarded a $465,000 Project Grant under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program to the Public Health Center of the Ministry of Health of Ukraine. The grant, awarded on Sep 29, 2023, supports an epidemiologic and molecular characterization study of Francisella tularensis, a potential biological threat agent, in the countries of the Black Sea region (Georgia, Turkey, Ukraine). The project will be carried out...
The American Type Culture Collection (ATCC) was awarded a $263,771 Project Grant from the Defense Threat Reduction Agency to conduct research titled "Genome-Wide Mapping (GWM) of Host Proteome: Pan Alphavirus Proteome Interactions for Discovery of Broad-Spectrum Countermeasures." The two-year project beginning October 12, 2021 aims to advance fundamental knowledge in scientific research combating weapons of mass destruction, as outlined in the agency's Scientific Research - Combating...

The federal Project Grant award HDTRA12510013, provided by the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program, aims to develop methods for the rapid identification of natural products in extracts and human protein targets. The $481,680 award, with a period of performance from May 1, 2025 to April 30, 2030, will be executed by the Puerto Rico Science, Technology, and Research Trust (PRSTRT), a minority-owned, Hispanic American-owned non-profit organization. The technical approach involves using high-resolution mass spectrometry with molecular networking to establish the chemical taxonomy of active compounds in natural product mixtures, as well as leveraging a human proteome array chip developed by CDI Laboratories to identify human protein targets within the mixtures. This project addresses a gap in the DTRA's Thrust Area 7 by expanding the resources and capabilities available for drug discovery and development pipelines, as well as medical countermeasure development platforms.

Generated 5/13/25, 5:21 AM